The first-in-human trial for tebentafusp findings are in, and they show promise for managing a patients side effects to it.
Alexander N. Shoushtari, MD
Advertisement
Articles by Alexander N. Shoushtari, MD
Advertisement
Latest Updated Articles
First-in-Human Trial for Tebentafusp In Advanced Melanoma Shows Promising Safety ProfilePublished: November 27th 2019 | Updated:
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Greenlights Niraparib/Abiraterone Acetate With Prednisone in mHSPC
2
Teclistamab/Daratumumab Increases OS, PFS in R/R Multiple Myeloma
3
Pembrolizumab Plus RT Ups T-Cell Infiltration in Early Breast Cancer
4
Oral Azacitidine Yields Similar PK to Subcutaneous Azacitidine in MDS/CMML
5
